Articles by Disease (Sepsis-associated Encephalopathy)

Bilirubin and Epigenetic Modifications in Metabolic and Immunometabolic Disorders

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22
Page: 1178-1190
Author(s): Mostafa Moradi Sarabi, Esmaeel Babaeenezhad, Maral Amini, Mozhgan Kaviani and Fakhraddin Naghibalhossaini*

Anti-Inflammatory Effect of Ginsenoside Rg1 on LPS-Induced Septic Encephalopathy and Associated Mechanism

Journal: Current Neurovascular Research
Volume: 19
Page: 38-46
Author(s): Yuan Chen, Miaomiao Chi, Xinyu Qiao, Jiabing Wang* and Yong Jin*

Non-hepatic Hyperammonemia: A Potential Therapeutic Target for Sepsis-associated Encephalopathy

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 21
Page: 738-751
Author(s): Lina Zhao, Yun Li, Yunying Wang, Zengzheng Ge, Huadong Zhu, Xiuhua Zhou and Yi Li*

Emerging Role of Interleukins for the Assessment and Treatment of Liver Diseases

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22
Page: 371-382
Author(s): Aaliya L. Ali, Namrata P. Nailwal and Gaurav M. Doshi*

Clinical Practice of Umbilical Cord Blood Stem Cells in Transplantation and Regenerative Medicine - Prodigious Promise for Imminent Times

Journal: Recent Patents on Biotechnology
Volume: 16
Page: 16-34
Author(s): Suman Kumar Ray and Sukhes Mukherjee*

Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19

Journal: Current Neuropharmacology
Volume: 20
Page: 1229-1240
Author(s): George B. Stefano*, Pascal Büttiker, Simon Weissenberger, Radek Ptacek, Fuzhou Wang, Tobias Esch, Thomas V. Bilfinger, Jiri Raboch and Richard M. Kream

Microbiome in Critical Care: An Unconventional and Unknown Ally

Journal: Current Medicinal Chemistry
Volume: 29
Page: 3179-3188
Author(s): Christian Zanza*, Tatsiana Romenskaya, Duraiyah Thangathurai, Veronica Ojetti, Angela Saviano, Ludovico Abenavoli, Chiara Robba, Gianmaria Cammarota, Francesco Franceschi, Andrea Piccioni and Yaroslava Longhitano